Modified Antibody for Targeted Drug Delivery and Reduced Immunogenicity

Modified Antibody for Targeted Drug Delivery and Reduced Immunogenicity

Bibliographic Details
Main Author:	Badkas, Apurva H.
Language:	English
Published:	University of Cincinnati / OhioLINK 2014
Subjects:	Chemical Engineering Drug Delivery Immunogenicity NP-Protein Modification
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=ucin1407410100

Similar Items

Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic Immunogenicity
by: Kathleen P. Pratt
Published: (2018-05-01)

Recent Advances in Chemically-Modified and Hybrid Carrageenan-Based Platforms for Drug Delivery, Wound Healing, and Tissue Engineering
by: Hamidreza Mokhtari, et al.
Published: (2021-05-01)

The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation
by: Thai Thanh Hoang Thi, et al.
Published: (2020-02-01)

Hepatic Cellular Distribution of Silica Nanoparticles by Surface Energy Modification
by: A-Rang Lee, et al.
Published: (2019-08-01)

Engineered Nanoparticle for Targeted and Controlled Drug Delivery
by: Zhou, Zilan
Published: (2017)

Editorial: Immunogenicity of Proteins Used as Therapeutics
by: Zuben E. Sauna, et al.
Published: (2020-10-01)

Overview of Antibody Drug Delivery
by: Sahar Awwad, et al.
Published: (2018-07-01)

Maytansine-bearing antibody-drug conjugates induce in vitro hallmarks of immunogenic cell death selectively in antigen-positive target cells
by: Maxine Bauzon, et al.
Published: (2019-04-01)

Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity
by: Satoshi Uchida, et al.
Published: (2015-07-01)

Strategies for the production of long-acting therapeutics and efficient drug delivery for cancer treatment
by: Alanod D. AlQahtani, et al.
Published: (2019-05-01)

Targeted Delivery of Protein Drugs by Nanocarriers
by: Antonella Battisti, et al.
Published: (2010-03-01)

Targeted Intracellular Delivery of Antibodies: The State of the Art
by: Tatiana A. Slastnikova, et al.
Published: (2018-10-01)

Applying MAPPs Assays to Assess Drug Immunogenicity
by: Anette C. Karle
Published: (2020-04-01)

USE OF SORPTION PROCESSES IN THE TECHNOLOGY OF DRUG DELIVERY SYSTEMS
by: A. V. Bondarev, et al.
Published: (2019-03-01)

Modified chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications
by: Tapan Kumar Giri, et al.
Published: (2012-10-01)

Bacteria as drug delivery vehicles
by: Wendel, Sebastian Oliver
Published: (2014)

Study of Zwitterionic Functionalized Materials for Drug Delivery and Protein Therapeutics
by: Lei, Xia
Published: (2019)

Synthesis and characterization of a modified surface of SBA-15 mesoporous silica for a chloramphenicol drug delivery system
by: Talib M. Albayati, et al.
Published: (2019-10-01)

Oxidatively Modified Proteins: Cause and Control of Diseases
by: Ramona Clemen, et al.
Published: (2020-09-01)

OVERVIEW OF PRE-CLINICAL TECHNIQUES FOR PREDICTING THE IMMUNOGENICITY OF THERAPEUTICS IN DRUG DEVELOPEMENT
by: Clarisse Musanabaganwa, et al.
Published: (2014-03-01)

Design of Coated Magnetic Iron-Oxide Nanogels for Drug Delivery Systems
by: Rahmani, Sara
Published: (2011)

Design of Coated Magnetic Iron-Oxide Nanogels for Drug Delivery Systems
by: Rahmani, Sara
Published: (2011)

Strategies for Improving Ocular Drug Bioavailability and Corneal Wound Healing with Chitosan-Based Delivery Systems
by: Teodora Irimia, et al.
Published: (2018-11-01)

Advanced modification of drug nanocrystals by using novel fabrication and downstream approaches for tailor-made drug delivery
by: Tao Liu, et al.
Published: (2019-01-01)

Nanoparticle Mediated Drug Delivery of Rolipram to Tyrosine Kinase B Positive Cells in the Inner Ear with Targeting Peptides and Agonistic Antibodies
by: Rudolf eGlueckert, et al.
Published: (2015-05-01)

Cationic Polymers for the Delivery of the Ebola DNA Vaccine Encoding Artificial T-Cell Immunogen
by: Larisa I. Karpenko, et al.
Published: (2020-12-01)

Antigenic and immunogenic properties of the canine distemper virus nucleocapsid protein expressed in Escherichia coli employing codon optimized synthetic gene
by: Maureen H.V. Fernandes, et al.

Immunopeptidomic Data Integration to Artificial Neural Networks Enhances Protein-Drug Immunogenicity Prediction
by: Carolina Barra, et al.
Published: (2020-06-01)

In vitro human helper T-cell assay to screen antibody drug candidates for immunogenicity
by: Shunsuke Ito, et al.
Published: (2019-01-01)

Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles
by: Yamir Islam, et al.
Published: (2021-06-01)

Targeting The CD4 Biniding Site In HIV-1 Immunogen Design
by: Bhattacharyya, Sanchari
Published: (2016)

The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies
by: David Baker, et al.
Published: (2020-02-01)

Targeted drug delivery for cancer therapy: the other side of antibodies
by: Firer Michael A, et al.
Published: (2012-11-01)

The use of protein structure/activity relationships in the rational design of stable particulate delivery systems
by: M.H.B. Costa, et al.
Published: (2002-06-01)

Biomacromolecules as carriers in drug delivery and tissue engineering
by: Yujie Zhang, et al.
Published: (2018-01-01)

Ultrasound-Induced Phase Change of Emulsion Droplets for Targeted Gene and Drug Delivery
by: Lattin, James R.
Published: (2012)

Novel Liposomes for Targeted Delivery of Drugs and Plasmids
by: Javadi, Marjan
Published: (2013)

Immunogenicity Assessment of Pegfilgrastim in Patients with Breast Cancer
by: Yu. V. Medvedev, et al.
Published: (2020-05-01)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
by: César López-Camacho, et al.
Published: (2019-11-01)

Curdlan 1,3-Beta-Glucans: A New Platform for Polymer Drug Delivery
by: Lehtovaara, Benjamin
Published: (2011)